Belgian biotech Galapagos came through with a $275 million IPO on the strength of its pipeline of immunology treatments, stirring hopes among a new crop of companies that the industry’s Wall Street window will remain open through the year.

…read more

Source: Galapagos pulls off a $275M IPO as biotech hopefuls eye $195M more


0 No comments